Edwards Lifesciences EW
NYSE EW
$91.16 -1.12 (-1.21%)
At close: Aug 20, 2026 · 10:54 AM UTC

Edwards Lifesciences (EW) Change in Accured Expenses (2009 - 2026)

Edwards Lifesciences (EW) posted quarterly Change in Accured Expenses of -$347.1 million for Q1 2026, down 235.69% year-over-year from $255.8 million in Q1 2025, and down 305.75% quarter-over-quarter from $168.7 million in Q4 2025.

Edwards Lifesciences (EW) Change in Accured Expenses (2009 - 2026) Analysis & Trends

Edwards Lifesciences' Change in Accured Expenses history runs 18 years deep, the most recent figure standing at -$347.1 million for Q1 2026.

  • In Q1 2026, Change in Accured Expenses fell 235.69% year-over-year to -$347.1 million; the TTM figure through Mar 2026 stood at $151.4 million (up 101.33% YoY), while the FY2025 annual figure was $395.1 million, up 341.45% from the prior year.
  • Change in Accured Expenses for Q1 2026 stood at -$347.1 million, down from $168.7 million in the prior quarter.
  • The five-year high for Change in Accured Expenses was $226.1 million in Q3 2025, with the low at -$347.1 million in Q1 2026.
  • The 5-year median for Change in Accured Expenses is $29.9 million (2024), against an average of $15.4 million.
  • The sharpest annual moves came in 2022 and 2025: Change in Accured Expenses sank 1074.19% in 2022, then jumped 5541.94% in 2025.
  • Edwards Lifesciences' Change in Accured Expenses stood at $34.3 million in 2022, then fell by 2.62% to $33.4 million in 2023, then sank by 109.28% to -$3.1 million in 2024, then surged by 5541.94% to $168.7 million in 2025, then plunged by 305.75% to -$347.1 million in 2026.
  • Business Quant data shows EW's Change in Accured Expenses at -$347.1 million in Q1 2026, $168.7 million in Q4 2025, and $226.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Abbott Laboratories 199.57 Bn 193.97 Bn 7.27 Bn -
2 Stryker 129.62 Bn 126.15 Bn 4.50 Bn 298.00 Mn
3 Medtronic 119.89 Bn 110.67 Bn 6.41 Bn 123.00 Mn
4 Boston Scientific 74.01 Bn 73.47 Bn 3.85 Bn 234.00 Mn
5 Edwards Lifesciences 52.48 Bn 48.23 Bn 1.35 Bn 123.70 Mn
6 Dexcom 34.64 Bn 32.69 Bn 830.00 Mn 112.90 Mn
7 GE HealthCare Technologies 33.90 Bn 31.79 Bn 2.18 Bn 19.00 Mn
8 Koninklijke Philips 26.41 Bn 23.09 Bn 4.55 Bn 43.01 Mn
9 Steris 23.16 Bn 22.68 Bn 684.20 Mn 4.80 Mn
10 Zimmer Biomet Holdings 19.35 Bn 18.94 Bn 1.54 Bn 92.00 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 123.70 Mn
Jun 30, 2026 123.70 Mn
Mar 31, 2026 -347.10 Mn
Mar 31, 2026 -347.10 Mn
Dec 31, 2025 168.70 Mn
Dec 31, 2025 168.70 Mn
Sep 30, 2025 226.10 Mn
Sep 30, 2025 226.10 Mn
Jun 30, 2025 103.70 Mn
Jun 30, 2025 103.70 Mn
Mar 31, 2025 -103.40 Mn
Mar 31, 2025 -103.40 Mn
Dec 31, 2024 -3.10 Mn
Dec 31, 2024 -3.10 Mn
Sep 30, 2024 29.90 Mn
Sep 30, 2024 29.90 Mn
Jun 30, 2024 151.80 Mn
Jun 30, 2024 151.80 Mn
Mar 31, 2024 -89.10 Mn
Mar 31, 2024 -89.10 Mn